Author | Wist, Martin | dc.contributor.author |
Date of accession | 2021-04-06T13:55:45Z | dc.date.accessioned |
Available in OPARU since | 2021-04-06T13:55:45Z | dc.date.available |
Date of first publication | 2020 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Dewey Decimal Group | DDC 570 / Life sciences | dc.subject.ddc |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
MeSH | Leukemia, Lymphocytic, Chronic, B-Cell | dc.subject.mesh |
MeSH | Type C phospholipases | dc.subject.mesh |
MeSH | Receptors, Antigen, B-Cell | dc.subject.mesh |
MeSH | Phosphoproteins | dc.subject.mesh |
MeSH | Protein kinase inhibitors; Therapeutic use | dc.subject.mesh |
Title | Molecular consequences of mutations in the gene encoding phospholipase C-gamma-2 causing immune dysregulation syndromes and resistance to ibrutinib in chronic lymphocytic leukemia | dc.title |
Resource type | Dissertation | dc.type |
Date of acceptance | 2020-12-14 | dcterms.dateAccepted |
Referee | Gierschick, Peter | dc.contributor.referee |
Referee | Johnsson, Nils | dc.contributor.referee |
PPN | 1753198178 | dc.identifier.ppn |
GND | Chronisch-lymphatische Leukämie | dc.subject.gnd |
GND | Phospholipase C | dc.subject.gnd |
Faculty | Fakultät für Naturwissenschaften | uulm.affiliationGeneral |
Institution | UKU. Institut für Pharmakologie und Toxikologie | uulm.affiliationSpecific |
Institution | Institut für Molekulare Genetik und Zellbiologie | uulm.affiliationSpecific |
Grantor of degree | Fakultät für Naturwissenschaften | uulm.thesisGrantor |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
Bibliography | uulm | uulm.bibliographie |